GLP-1 dosing is customized based on your bodys response, including appetite changes, tolerance, energy levels, and progress
In June 2025, the TGA issued a medicines safety update requiring consideration be given to the risk of delayed gastric emptying and aspiration when providing anaesthesia or deep sedation for patients using these drugs
source: Policosanol 60% Policosanol seems to decrease cholesterol production in the liver and to increase the breakdown of LDL (low-density lipoprotein or bad) cholesterol
These pharmaceutical agents work by mimicking the action of endogenous GLP-1, an incretin hormone secreted by intestinal L-cells in response to food intake
We accept patients in 49 states and offer various GLP-1 medications (availability may vary by state)
There are no sources of gluten, soy, or milk listed, so it is free from those ingredients